Lab co-authors new Cancer Letters study on PDAC therapeutic resistance

Dr. Liu and colleagues in the Department of Cell and Cancer Biology published "A PP2A-mtATR-tBid axis links DNA damage-induced CIP2A degradation to apoptotic dormancy and therapeutic resistance in PDAC" in Cancer Letters, identifying a mitochondrial signaling axis that drives chemoresistance in pancreatic ductal adenocarcinoma.

Read the paper: https://doi.org/10.1016/j.canlet.2025.217790